← Back to All Filings

Boston Scientific EVP Gifts 10,300 Shares in Routine Filing

Low SignificanceNovember 14, 2025 at 5:32:10 PM EST

BOSTON SCIENTIFIC CORP

$BSX4CIK: 0000885725

Subscribe to track BSX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Boston Scientific EVP Gifts 10,300 Shares in Routine Filing

Company: BOSTON SCIENTIFIC CORP (BSX) Form: 4 | Filed: 2025-11-14 Significance: Low

Insider: Fitzgerald Joseph Michael Title: EVP & Group Pres, Cardiology | Relationship: Officer

Transaction: • Type: Gift • Shares: 10,300 • Price: $0.00 • Value: $0 • Owned After: 168,042 (Directly)

Key Insight: An executive gifted shares, a non-market transaction often related to estate planning. The size is negligible compared to the company's market cap.

Market Context: For a large-cap company like BSX ($155.63B), this transaction is immaterial and not indicative of a change in insider sentiment regarding the company's performance.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: BOSTON SCIENTIFIC CORP (BSX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An executive made a small, non-market gift of shares, which holds no significance for the broader market.
  • Market Impact: Neutral. The transaction is too small to influence market sentiment or trading volume.

Company Information

FieldValue
CompanyBOSTON SCIENTIFIC CORP
Ticker SymbolBSX
CIK0000885725
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameFitzgerald Joseph Michael
CIK0001484186
Title/PositionEVP & Group Pres, Cardiology
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-14
Transaction CodeG (Gift)
Security TypeCommon Stock
Shares Involved10,300
Price Per Share$0.00
Total Value$0
Shares Owned After168,042
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.000%
Shares Transacted10,300
% of Shares Outstanding0.0007%
Post-Transaction Ownership168,042 shares (0.011% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $155.63 billion, this transaction is financially negligible.
  • Ownership Concentration: The insider's post-transaction ownership of 0.011% is a very small fraction of the total shares outstanding, indicating low ownership concentration.
  • Transaction Significance: The transaction represents less than 0.001% of the company's outstanding shares, falling far below any threshold for market significance. Gifts are typically non-indicative of an insider's outlook on the company's future performance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a gift (Code 'G'), not a market sale or purchase. Its size is immaterial relative to the company's market capitalization and public float.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is too small to affect trading volume.
  • Sentiment Indicator: Neutral. Gifts are not considered signals of bullish or bearish sentiment.

Additional Context

Transaction Notes

  • The filing reports two separate gift transactions totaling 10,300 shares disposed of at $0.00 per share. Such transactions are common for personal estate planning or charitable donations and do not reflect market sentiment.
Topics:#SECFiling#InsiderTrading#BSX#BostonScientific#Form4#StockMarket#Finance#Executive#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.